A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers
Status:
Completed
Trial end date:
2009-07-06
Target enrollment:
Participant gender:
Summary
This is a drug-drug interaction study; the purpose of this study is to examine the
pharmacokinetics (levels of drug in the blood) of SPD503 (guanfacine hydrochloride) and
Concerta (methylphenidate HCl) when given alone, and in combination.